These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 6944530)
1. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530 [TBL] [Abstract][Full Text] [Related]
2. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients. Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790 [TBL] [Abstract][Full Text] [Related]
4. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients. Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354 [TBL] [Abstract][Full Text] [Related]
5. Generation of suppressor cells for natural killer activity in cancer patients after surgery. Uchida A; Kolb R; Micksche M J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792 [TBL] [Abstract][Full Text] [Related]
6. Regional hyperplastic lymph nodes in breast cancer: the role of lymphocytes and nodal macrophages. An immunological study with a five-year follow-up. Hickok DF; Miller L; Harris L Surgery; 1977 Nov; 82(5):710-5. PubMed ID: 199957 [TBL] [Abstract][Full Text] [Related]
7. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells. Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523 [TBL] [Abstract][Full Text] [Related]
8. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast. Check IJ; Cobb M; Hunter RL Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870 [TBL] [Abstract][Full Text] [Related]
9. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer]. Kadoyama C; Kimura H; Yamaguchi Y Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205 [TBL] [Abstract][Full Text] [Related]
10. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer]. Hisamatsu K; Toge T; Yanagawa E; Hamada Y; Seto Y; Yamada H; Toi M; Hattori T Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228 [TBL] [Abstract][Full Text] [Related]
11. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer. Saxon A; Portaro J Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients. Wong PY; Staren ED; Tereshkova N; Braun DP J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer. Kadoyama C; Kimura H; Yamaguchi Y Jpn J Clin Oncol; 1987 Mar; 17(1):29-39. PubMed ID: 2951535 [TBL] [Abstract][Full Text] [Related]
14. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy. Kurosu Y; Saegusa Y; Tominaga M; Morita K Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651 [TBL] [Abstract][Full Text] [Related]
15. Depression of the generation of cell-mediated cytotoxicity in regional lymph nodes of patients with gastric carcinoma. Koba F; Akiyoshi T; Tsuji H J Clin Lab Immunol; 1987 Apr; 22(4):181-4. PubMed ID: 3497276 [TBL] [Abstract][Full Text] [Related]
16. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients]. Moritani Y Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484 [TBL] [Abstract][Full Text] [Related]
17. Assessment of host immune response in breast cancer patients. Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806 [TBL] [Abstract][Full Text] [Related]
18. Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes. Vose BM; Vánky F; Argov S; Klein E Eur J Immunol; 1977 Nov; 7(11):353-7. PubMed ID: 304003 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer. Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800 [TBL] [Abstract][Full Text] [Related]
20. Stages of the development of immunologic response in regional lymph nodes draining breast cancer. Kozlowski H; Hrabowska M Neoplasma; 1978; 25(4):445-52. PubMed ID: 308619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]